Press Releases Items Per Page 102550 News Category FinancialGeneral Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Nektar Therapeutics Reports First Quarter 2011 Financial Results Apr 27, 2011 FDA Grants Orphan Drug Designation for Nektar's Investigational Drug, NKTR-102, for Treatment of Women with Ovarian Cancer Apr 21, 2011 Nektar to Announce Financial Results for the First Quarter of 2011 on Wednesday, April 27, 2011, After Close of U.S.-Based Financial Markets Apr 18, 2011 Nektar Initiates Phase 1 Clinical Study Evaluating NKTR-181, A Novel Opioid Molecule, for Treatment of Pain Mar 21, 2011 AstraZeneca Initiates Phase III Clinical Programme Evaluating NKTR-118 for Treatment of Opioid-Induced Constipation Mar 15, 2011 Nektar Therapeutics Reports Fourth Quarter and Year End 2010 Financial Results Mar 01, 2011 Nektar Therapeutics' President and CEO Howard W. Robin to Present at the 31st Annual Cowen and Company Healthcare Conference in Boston Mar 01, 2011 Nektar to Announce Financial Results for the Fourth Quarter and Year-End of 2010 on Tuesday, March 1, 2011, After Close of U.S.-Based Financial Markets Feb 17, 2011 Nektar Therapeutics Completes Public Offering of Common Stock Jan 24, 2011 Nektar Therapeutics Prices Public Offering of Common Stock Jan 19, 2011 Pagination First page « first Previous page ‹ previous … Page 33 Page 34 Page 35 Page 36 Current page 37 Page 38 Page 39 Page 40 Page 41 … Next page next › Last page last »